Speaker illustration

Doctor Makoto Kishihara

Saiseikai Kazo Hospital, Saitama (Japan)

Beta-blocker could show the prognostic impact in heart failure patients even on the regular hemodialysis

Event: ESC Congress 2021 - The Digital Experience

Topic: Pharmacotherapy

Session: Chronic heart failure e-posters

Thumbnail

ESC 365 is supported by

logo Novo Nordisk